BioWorld Recognized for Excellence of Information & Intelligence to Biopharmaceutical Industry

News service from Clarivate wins plethora of awards at 41st Annual SIPAwards

LONDON and PHILADELPHIA, June 10, 2020 /PRNewswire/ -- BioWorld™, a part of Clarivate Plc (NYSE:CCC), a global leader in providing trusted information and insights to accelerate the pace of innovation, has been recognized for excellence in publishing by the Specialized Information Publishers Association (SIPA). BioWorld, the daily news service for biopharmaceutical and medical technology industries, is the recipient of seven SIPAwards.

BioWorld delivers actionable information and intelligence on the most innovative therapeutics and medical technologies in development. The global team reports breaking news and provides key perspectives on hundreds of therapeutics and devices in development - the companies behind those candidates, the business development transactions that evolve the markets, and the regulatory hurdles that both challenge and guard the processes.

Lynn Yoffee, News Director, BioWorld said, "Every day, we help our readers cut through the noise of information overload. Now ― more than ever ― it is increasingly vital that we continue to provide our readers with unique, compelling and quality content that enables drug and med-tech developers to make more informed decisions."

SIPA hosts the annual SIPAwards competition to recognize excellence in editorial, marketing and product success. Now in its 41^st year, the awards highlight the information and insights provided to niche audiences around the world.  BioWorld is now the recipient of 63 SIPAwards dating back to 1998, including 15 awards for its daily news service. This year it was honored in the following categories:

Best Daily Publication
For high-impact daily information.

• First Place: BioWorld
• Third Place: BioWorld MedTech

Best New or Relaunched Website
For outstanding website design and maneuverability within a site.

• First Place: BioWorld and BioWorld MedTech for its entry, titled "Hello Future, Goodbye PDF,"

Best Series
For best series, based on writing, editing and design; the scope and detail of coverage in the stories; the timeliness or "exclusive" value.

• First Place: BioWorld and BioWorld MedTech - Transforming drug, med-tech R&D with AI 

Best Infographic
For infographics that clearly and concisely present information, processes or data consistent with the subject matter, target industry and voice of the media outlet.

• First Place: BioWorld, Karen Carey - Biopharma stocks up 26% on average since debut with Karuna

Best Use of Data
For work in which data plays an essential role. The work may feature any of several forms and formats, (e.g., infographics, trend analyses, blogs, interactive tools, data-based investigation) to enhance its overall effectiveness.

• Third Place: BioWorld, Karen Carey ― Generic approvals up 28% amid drug pricing concerns

Best Interpretive or Analytical Reporting, Healthcare/Regulatory/Education
For excellent interpretive or analytical reporting covering the healthcare, regulatory and education sectors, with an analysis or explanation of a difficult topic or idea.

• Third Place: BioWorld MedTech, Stacy Lawrence ― Experimental treatment could free patients with advanced type 2 diabetes from daily insulin injections

About Clarivate  

Clarivate™ is a global leader in providing trusted information and insights to accelerate the pace of innovation. We offer subscription and technology-based solutions coupled with deep domain expertise that cover the entire lifecycle of innovation – from foundational research and ideas to protection and commercialization. Today, we're setting a trail-blazing course to help customers turn bold ideas into life-changing inventions. Our portfolio consists of some of the world's most trusted information brands, including the Web of Science™, Cortellis™, Derwent™, CompuMark™, MarkMonitor™ and Techstreet™. For more information, please visit clarivate.com. 

Logo - https://mma.prnewswire.com/media/1159266/Clarivate_Analytics.jpg